Home
Shares
News Centre
F&O
Mutual Funds
IPO
Portfolio
Commodity
Loans
Financial Planning
Insurance
About Us
Markets
Companies
Research
Industries
E-Mail Page
Get NAV
Snapshot
Portfolio
Dividends
News
Interviews
Charts
Get Quote
Snapshot
Charts
Financials
Research
News
Wealth Tracker
Tax Corner
NRI Centre
Chat Masala
Feedback
my
Last 5 Scrips
Company
BSE Price(Rs)
% Chg
Yes Bank
14.00
Tata Mot
294.00
State Ba
336.45
Ntpc Ltd
102.55
3.38
Power Gr
210.75
3.51
Clear All
Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Aurobindo Pharma Limited
Aurobindo Pharma Limited
Sector:Pharmaceuticals
Pharmaceuticals - Bulk Drugs
BSE:
524804
NSE:
AUROPHARMA
Bloomberg:
ARBP@IN
Reuters:
ARBN.BO
Market Lot: 1
Face Value: 1
ISIN Demat: INE406A01037
Quotes
Snapshot
Charts
Financials
Research
Recent News
Peer Group
AGM/AM
MF Holding
Discussion Forum
BSE/NSE Notices
BSE/NSE Deals
Corporate News
19-Feb-2021
Aurobindo Pharma gets USFDA nod for Droxidopa Capsules
IRIS
09-Dec-2020
Aurobindo Pharma gets USFDA nod for dexmedetomidine injection
IRIS
23-Apr-2020
Buy Aurobindo Pharma, target price Rs 770: ICICI Direct
IRIS
24-Feb-2020
Aurobindo Pharma locked in lower circuit as USFDA reopens investigation of Hyd unit
IRIS
21-Feb-2020
USFDA revokes Aurobindo Pharma's VAI status for Hyderabad unit
IRIS
19-Feb-2020
Aurobindo Pharma receives EIR for Hyderabad unit
IRIS
11-Feb-2019
Aurobindo Pharma completes acquisition of businesses in 5 European countries
IRIS
18-Jan-2019
Aurobindo Pharma to acquire portfolio of oncology injectables products
IRIS
18-Sep-2018
Aurobindo Pharma receives approval from South African health regulator
IRIS
06-Sep-2018
Aurobindo Pharma to acquire dermatology, oral solids biz from US based-Co
IRIS
30-Jul-2018
Aurobindo Pharma receives final approval for Bivalirudin injection
IRIS
16-Jul-2018
Aurobindo Pharma to acquire Apotex' biz in 5 countries
IRIS
11-Jul-2018
Aurobindo Pharma receives USFDA approval for Azithromycin Tablets
IRIS
02-Jul-2018
Aurobindo Pharma receives USFDA approval for Ibuprofen OTC Capsules
IRIS
26-Jun-2018
Aurobindo Pharma receives USFDA approval for Ertapenem injection
IRIS
08-Jun-2018
Aurobindo Pharma gets nod for Omeprazole DR tablets
IRIS
29-May-2018
Aurobindo Pharma quarterly net declines 0.64%
IRIS
Home
|
Shares
|
F&O
|
Mutual Funds
|
Loans
|
Insurance
|
News Centre
Wealth Tracker
|
Tax Corner
|
NRI Centre
|
Search in myiris
|
Advertise
© All rights reserved. IRIS Business Services Limited
Disclaimer